Search

Author/Creator Block, S

1. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Issue 9 (13th April 2004)

Authors:
Cohen, S B; Moreland, L W; Cush, J J; Greenwald, M W; Block, S; Shergy, W J; Hanrahan, P S; Kraishi, M M; Patel, A; Sun, G; Bear, M B
Other Names:
group-author.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 63:Issue 9(2004)
Page Start:
1062
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P723 Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE). (16th January 2018)

Authors:
Reenaers, C; Cremer, A; Dewit, O; de Vroey, B; Van Moerkercke, W; Bossuyt, P; Muls, V; Imschoot, J; Block, S; Hantson, A; Van Hootegem, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S476
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗